Predicting somatic mutations with OncMTR
The latest high impact publication from our Centre for Genomics Research reveals how our novel tool OncMTR can pinpoint non-inherited (somatic), missense mutations in the genome that may contribute to cancer risk. Published in Science Advances, the research showed that by analysing DNA sequences from over 120 thousand human blood samples, OncMTR could effectively predict driver mutations of haematologic malignancies.
Find out how OncMTR is helping our researchers to develop more focused and novel therapies to treat cancer and the important implications of this first-of-its-kind DNA pattern recognition tool for precision medicine approach.
https://www.science.org/doi/10.1126/s...
------------------------------------------------------------
Global site: https://www.astrazeneca.com/
Careers site: https://careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazenecacareers